1. |
Kim HD, Hwang SM, Lim KR, et al. Recurrent auricular keloids during pregnancy. Arch Plast Surg, 2013, 40(1): 70-72..
|
2. |
Mauviel A. Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol Med, 2005, 117: 69-80.
|
3. |
陈勇, 戴和平, 龙志高, 等.人皮肤成纤维细胞的分离和体外培养.湖南医科大学学报, 2002, 27(5): 477-478.
|
4. |
夏鹏, 童文祥, 喻永敏, 等.大鼠皮肤切创愈合过程中VEGF, TGF-β蛋白的表达.重庆医科大学学报, 2010, 35(8): l167-1171.
|
5. |
Liang CJ, Yen YH, Hung LY, et al. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway. Biochem Pharmacol, 2013, 85(11): 1594-1602.
|
6. |
Wu CS, Wu PH, Fang AH, et al. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Br J Dermatol, 2012, 167(3): 532-541.
|
7. |
Kottler UB, Jünemann AG, Aigner T, et al. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res, 2005, 80(1): 121-134.
|
8. |
Chang Z, Kishimoto Y, Hasan A, et al. TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in ruts. Dis Model Mech, 2013, 7(1): 83-91.
|
9. |
Falk P, Angenete E, Bergstrom M, et al. TGF-β1 promotes transition of mesothelial cells into fibroblast phenotype in response to peritoneal injury in a cell culture model. Int J Surg, 2013, 11(9): 977-982.
|
10. |
Attisanno L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science, 2002, 296(5573): 1646-1647.
|
11. |
ten Dijke P, Miyazono K, Heldin CH. Signaling inputs converge on nuclear effectors in TGF-βsignaling. Trends Biochem Sci, 2000, 25(2): 64-70.
|
12. |
李春辉, 潘理会, 张德利.胃癌组织TGF-β、Smad7与ki-67 mRNA表达及其相关性分析.实用医学杂志, 2014, 30(5): 751-754.
|
13. |
Yu F, Guo Y, Chen B, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest, 2015, 95(7): 781-789.
|
14. |
Brodin G, ten Dijke P, Funa K, et al. Increased Smad expression and activation is associated with apoptosis in normal and malignant prostate after castration. Cancer Res, 1999, 59(11): 2731-2738.
|
15. |
Landström M, Heldin NE, Bu S, et al. Smad7 mediates apoptosis induced by transforming growth factorβin prostatic carcinoma cells. Curr Biol, 2000, 10(9): 535-538.
|
16. |
Kamato D, Burch M, Piva TJ, et al. Transforming growth factor-βsignalling:Role and consequences of Smad linker region phosphorylation. Cells Signal, 2013, 25(10): 2017-2024.
|
17. |
Ladin DA, Hou L, Patel D, et al. P53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen, 1998, 6(1): 28-37.
|
18. |
Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation:possible implications in the etiology of keloid. Am J Pathol, 1996, 149(5): 1441-1447.
|
19. |
Crowston JG, Chang LH, Constable PH, et al. Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. Invest Ophthalmol Vis Sci, 2002, 43(3): 692-699.
|
20. |
刘永波, 高建华, 段红杰, 等.瘢痕疙瘩p53基因突变高发区基因结构的研究.中华整形外科杂志, 2003, 19(4): 258-260.
|